In the eukaryotic process of autophagy, or 'self-eating' , a doublemembrane phagophore, the precursor to an autophagosome, engulfs a portion of the cytoplasm, and the autophagosome then fuses with lysosomes or the vacuole for degradation of the cytosolic contents. This can allow recycling of macromolecules when cells are starved of nutrients or elimination of defective or unneeded organelles or cytoplasmic assemblies.
a r t i c l e s
In the eukaryotic process of autophagy, or 'self-eating' , a doublemembrane phagophore, the precursor to an autophagosome, engulfs a portion of the cytoplasm, and the autophagosome then fuses with lysosomes or the vacuole for degradation of the cytosolic contents. This can allow recycling of macromolecules when cells are starved of nutrients or elimination of defective or unneeded organelles or cytoplasmic assemblies.
Core functions of autophagy are mediated by noncanonical UBL cascades. Best characterized in the yeast Saccharomyces cerevisiae, the two UBLs Atg8 and Atg12 are both activated by the same E1 enzyme, Atg7, which, by mechanisms that are not well understood, directs each UBL to an E2 enzyme, Atg3 or Atg10, respectively [1] [2] [3] . Ultimately, the Atg7 and Atg3 cascade ligates Atg8's C-terminal glycine to phosphatidylethanolamine (PE). Here a tilde (~) denotes thioester-or peptide-bonded covalent complexes. Atg8~PE adducts are incorporated into the growing autophagosomal membrane in a process that is critical for its expansion, and Atg8 also recruits cargo during selective autophagy 4, 5 . The other autophagic UBL, Atg12, functions after Atg7-and Atg10-mediated ligation to Atg5 to enhance Atg8 lipidation [6] [7] [8] [9] [10] [11] . The importance of Atg7, Atg3, Atg10 and other components of the Atg8 and Atg12 ligation pathways is reflected by numerous pathologies observed in cells, tissues and/or animals lacking these proteins [12] [13] [14] [15] . Thus, it is of great significance to understand the molecular mechanisms underlying UBL conjugation in autophagy.
Enzymes in the Atg8 and Atg12 conjugation cascades are termed noncanonical, owing to substantial differences from those for UBLs such as ubiquitin, NEDD8 and SUMO 16 . Unlike progress in understanding the structural characteristics of enzymes involved in canonical UBL conjugation cascades, knowledge of the noncanonical features underlying Atg8 and Atg12 conjugation remains relatively rudimentary. Briefly, in canonical UBL cascades as well as noncanonical cascades in autophagy, an E1's structurally conserved adenylation domain binds the UBL and catalyzes its C-terminal adenylation [17] [18] [19] [20] . However, in Atg7, the adenylation domain is a symmetric homodimer with two identical UBL-binding-and-adenylation active sites, whereas the adenylation domains from canonical E1s are pseudosymmetric and contain only a single UBL-binding-and-adenylation active site [21] [22] [23] . The UBL C terminus subsequently becomes covalently attached to the E1 catalytic cysteine by a thioester bond. In canonical E1s, the catalytic cysteine is housed in a distinct domain 18 that undergoes remarkable structural remodeling to form an E1~UBL thioester intermediate 24 .
By contrast, Atg7's cysteine is in a flexible loop that crosses over the UBL-binding surface and approaches an autophagy UBL's C-terminal glycine in the adenylation active site [21] [22] [23] . Thus, structurally, Atg7 has a single C-terminal domain (CTD) that contains the elements for both UBL adenylation and formation of the Atg7~UBL thioester intermediate. Next, a UBL thioester is transferred to an E2 catalytic cysteine in order to ultimately shuttle the activated UBL to targets. However, the mechanisms by which canonical and noncanonical E1s recruit their E2s differ completely. Canonical E1s recruit their cognate E2s by a selective ubiquitin-fold domain (UFD) at the C terminus of the same subunit that also harbors the adenylation active site and catalytic cysteine 16, 25, 26 . By contrast, Atg7 lacks a UFD and instead has a unique N-terminal domain (NTD) that binds autophagic E2s (refs. 21-23) . For Atg3 this was shown to use a unique trans architecture: Atg3 binds the NTD of one Atg7 and receives Atg8 from the catalytic cysteine of the opposite Atg7 molecule in the homodimer [21] [22] [23] .
The autophagy E2s also have distinctive features that raise questions about how both Atg3 and Atg10 could bind Atg7. First, Atg3 and Atg10 share little sequence homology. Although they both have core structures resembling a canonical E2 catalytic domain, with a concave β-sheet backside and the catalytic cysteine at the front, their mechanisms of E1 binding are apparently noncanonical 27, 28 . Atg3 lacks any known catalytic residues other than the active site cysteine and also has a unique 'flexible region' (Atg3FR) that binds Atg7 and a distinctive 'handle region' required for downstream steps in Atg8 lipidation 27 . A prior structure of a short peptide from the Atg3FR bound to the isolated Atg7NTD revealed the basis for their high-affinity interactions, although additional contact surfaces were implied 21 . Also, it is unclear how Atg10 binds Atg7: Atg10 lacks an obvious flexible-region sequence, and an Atg7 mutant at the Atg3FR-binding interface is defective for the Atg3 pathway but not for the Atg10 pathway in vivo 21 . Seemingly paradoxically, the isolated Atg3FR competes with Atg10 for Atg7 binding in vitro, and the Atg7-binding site on Atg3FR is not accessible in the prior structure of full-length Atg3 (refs. 23,27) .
Thus, to gain insights into how the autophagy E1 recognizes its E2s, we determined crystal structures of Atg7-Atg3 and Atg7-Atg10 complexes from S. cerevisiae. The structures show how a single E1 enzyme uses the same surfaces to recognize distinctive features of two different E2s and how conformational changes and unique molecular architectures mediate active site juxtaposition for the noncanonical E1-E2 complexes in autophagy.
RESULTS

Multisite recruitment of Atg3 and Atg10 to Atg7
To visualize the juxtaposition of E1 and E2 catalytic cysteines, which is required for UBL transfer, we performed cross-linking as follows: We purified versions of Atg3 and Atg10 containing only a single cysteine at the active site, reacted the homobifunctional sulfhydryl cross-linker bismaleimidoethane (BMOE) with each E2 and desalted excess crosslinker. For Atg3, we added a version of Atg7 lacking the C-terminal 17 residues disordered in prior crystals, and for Atg10 we added a version of Atg7 with this truncation and C39S C195S C375A mutations to reduce background cross-linking. Using this method, we obtained crystal structures of Atg7-BMOE-Atg3 and Atg7-BMOE-Atg10 (hereafter referred to as Atg7-Atg3 and Atg7-Atg10) to 2.7-and 2.9-Å resolution, respectively ( Table 1 and Supplementary Fig. 1 ). Both contain one dimeric Atg7 bound to two E2s per asymmetric unit.
The structure of Atg7 resembles a bird, with the two NTDs corresponding to 'wings' extending away from the symmetric homodimeric CTD 'body' (Fig. 1a and Supplementary Fig. 2a) . The relative NTD-CTD orientations differ by ~10° between all the E2-bound and the unbound Atg7 structures 22 , which translates into ~40-Å differences in the distal-edge positions for the oblong NTD. The range of NTD positions observed upon superimposing the E2-bound and apo-Atg7 structures over their CTDs resembles the flapping of a bird's wings. Conformational flexibility between the Atg7NTD and CTD is likely important to accommodate the different dimensions of the Atg3 and Atg10 E2s and is consistent with prior small-angle X-ray scattering data 21, 22 . 
The E2 core domain of Atg7-bound Atg3 superimposes well with the prior uncomplexed structure 27 , although in the complex the Atg3 catalytic-cysteine loop is substantially rearranged, and much of the handle region is not visible (Fig. 1b) . In both the free and Atg7-bound Atg3 structures, the majority of the flexible region is disordered, except for a small helical segment. However, this region of the Atg3FR is substantially displaced in the complex with Atg7: instead of packing against Atg3's own E2 core domain, the flexibleregion helix interacts with a distal groove in the 'shoulder' region of the Atg7NTD wing.
Despite little apparent overall sequence similarity, Atg10 also generally resembles a canonical E2 core domain. Although the C-terminal structures differ between Atg3, Atg10 and canonical E2s, their catalytic domains have in common an N-terminal helix, a backside four-stranded antiparallel β-sheet followed by the cysteine loop and a long central helix 28 (Fig. 1b) . One notable difference in Atg10 when compared to Atg3 and other E2s is C-terminal extension of the fourth β-strand and its continuation into a β-hairpin that leads to an additional strand incorporated into an extended β-sheet on the E2 backside (Fig. 1b) .
Common Atg7 surfaces recruit the E2s through extensive multipart interfaces involving (i) the shoulder portion of the Atg7NTD wing interacting with unique structures from the backsides of Atg3 and of Atg10, (ii) the 'under-wing' portion of the NTD interacting with features along the length of the backsides of both E2s and (iii) the Atg7 NTD-CTD junction cradling the edge of both E2s (Fig. 2a,b ). Atg7's multisite recruitment buries ~2,450 and ~1,830 Å 2 from Atg3 or Atg10, respectively, which corresponds to ~30% of their exposed surfaces.
The structurally observed Atg7NTD recruitment of an autophagic E2 by its backside allows juxtaposition of the E2 frontside active site with the catalytic cysteine in the CTD of the opposite Atg7 molecule in the homodimer (Fig. 2) . This trans configuration agrees with previous biochemical studies of Atg7-Atg3 complexes. To test whether this trans architecture also exists in solution for Atg7-Atg10 complexes, we performed cross-linking based on previously described mixed dimer versions of Atg7 (refs. 21,22) . In the trans configuration, one Atg7 molecule Figure 2 Overall trans architectures of autophagy E1-E2 complexes. (a) Structure of catalytic cysteine-to-cysteine cross-linked Atg7-Atg3 complex, with the two Atg7 protomers in the homodimer in violet and pink, the two Atg3 molecules in teal and cyan and their catalytic cysteines shown as spheres. In the crystal, Atg3 binds noncovalently to the NTD from one Atg7 protomer, and its catalytic cysteine, approaching that from the opposite Atg7 in the homodimer, is circled. The circled cysteines are cross-linked by BMOE. The two proteins from each dimer are indicated by (1) and (2). (b) Structure of catalytic cysteine-tocysteine cross-linked Atg7-Atg10 complex, with the two Atg7 protomers in the homodimer in violet and pink, the two Atg10 molecules in teal and cyan. Atg7 catalytic cysteines are shown as spheres, as is the Cα from Pro132 (molecule 1) and His131 (molecule 2) of Atg10. For the Atg10s, the catalytic Cys133 and loop are represented with dotted lines. In the crystal, Atg10 binds noncovalently to the NTD from one Atg7 protomer, and its catalytic cysteine loop, approaching that from the opposite Atg7 in the homodimer, is circled. The circled cysteines are cross-linked by BMOE. (c) Coomassie-stained SDS-PAGE showing BMOE cross-linking between catalytic cysteine-only versions of Atg3 and Atg10 and cis-Atg7c or trans-Atg7t Atg7-Atg7CTD heterodimers. In Atg7c, only full-length Atg7 has an active site cysteine; in Atg7t, only the CTD has a catalytic cysteine. Control reactions were pretreated with DTT as indicated to eliminate BMOE cross-linking. The numbers on the left of the blot are molecular weight standards. Atg7 (1) Atg7 (2) Atg7 (1) Cys Atg10 (2) Cys loop Atg10 (1) Atg10 (2) Atg7 ( a r t i c l e s consists only of the CTD, which retains the catalytic cysteine but lacks the E2-binding NTD. The other Atg7 retains the E2-binding NTD but carries an active site cysteine-to-alanine substitution in the CTD. In the cis configuration, the Atg7CTD harbors a catalytic cysteine-to-alanine mutation, and the full-length Atg7 retains both the E2-binding NTD and the catalytic cysteine. Mixed heterodimers are stabilized by an engineered salt bridge between glutamate and arginine substitutions in place of residues 511 and 524, respectively 22 , and are ensured by a sequential two-tag purification strategy 21 . After reacting single-cysteine versions of either Atg3 or Atg10 with BMOE, desalting and adding one of the two forms of Atg7, cross-linking was observed only with the trans version of Atg7, consistent with the crystallographic architectures (Fig. 2c) .
E2 recruitment to a conserved Atg7NTD shoulder groove
An ~30-Å-long, conserved hydrophobic groove in the shoulder region of the Atg7NTD wing anchors the two autophagy E2s in completely different ways. From Atg3, the unique flexible-region helix is embedded in the portion of the shoulder groove lined by Leu90, Phe93, Lys94, Lys98, Arg135, Tyr137, Trp139, Trp273, Lys280, Leu281, Pro283 and Val285 from the Atg7NTD (Fig. 3a) , as in the prior structure of the isolated Atg7NTD bound to a short Atg3FR-helix peptide 21 . Although the 45 residues preceding the flexible-region helix are disordered in the Atg7-Atg3 complex, there is patchy electron density corresponding to the residues following the helix. Notably, this unmodeled density traverses a basic surface in the middle of Atg7's NTD, probably reflecting electrostatic interactions from up to 12 of the 20 residues in this Atg3 region that are acidic or polar (Supplementary Figs. 3 and 4) . The importance of Atg7's shoulder carrying Atg3's flexible region is highlighted by the previous finding that deleting the flexible region substantially increases the K d for Atg7 binding 21 . From Atg10, the β-hairpin binds the edge of the shoulder groove (Fig. 3b) . Here, Atg10's Ile88, Asp89, Ile91 and Pro92 are enwrapped in a pocket formed by Atg7's Arg135, Tyr137, Asn276, Val277, Gln278, Ala282, Pro283, Val285 and Asp287. The interaction is stabilized by salt bridges between Atg7's Lys94 and Atg10's Asp89, as well as between Atg7's Asp287 and Ser290 and Atg10's Lys95. Notably, the additional β-strand in Atg10's sheet aligns with Atg7's β-strand 15. This leads to formation of a ten-stranded interprotein β-sheet with five strands each from Atg10's backside and Atg7's NTD.
Comparison of Atg3 and Atg10 contacts with the shoulder groove resolves previous seemingly contradictory findings. Some overlap of the interaction surfaces (Fig. 3c) explains why the Atg3FR competed with Atg10 for binding to the Atg7NTD during gel filtration 23 . Although we wished to further probe the competition, unfortunately we have not npg a r t i c l e s been able to purify S. cerevisiae Atg12. Thus, we developed an artificial enzyme assay: using high protein concentrations in vitro, we can observe non-native Atg7-mediated conjugation of Atg8 onto Atg10 at low levels. This reaction is inhibited by the short peptide corresponding to the Atg3FR helix (Fig. 3d) , consistent with the structures.
Despite overlapping binding surfaces, the distinct E2 binding modes suggest that different Atg7 residues from the shoulder groove have critical roles in recruiting Atg3 or Atg10. In particular, the Pro283 side chain is central to the hydrophobic interaction with Atg3FR but is at the edge of the Atg10-binding surface. By contrast, Val285 is at the center of the hydrophobic interface with the Atg10 β-hairpin but is on the edge of the Atg3-binding surface. At a more intermediate level, Tyr137 also has a modest role in the Atg3 interaction but appears to stabilize the structure of the Atg10-binding site. We tested these concepts with Atg7-E2 catalytic-cysteine cross-linking assays (Fig. 3e,f) . In agreement with the structures, mutation of Atg7's Tyr137 had modest effects on crosslinking to both E2s. However, a P283D substitution shown previously to impair Atg7-Atg3 interactions had little effect on Atg10 cross-linking to Atg7, whereas a V285D substitution almost abolished Atg7 cross-linking to Atg10 but not to Atg3. Deleting Atg10's β-hairpin (residues 86-93) also substantially diminished cross-linking to Atg7 (Fig. 3g) . Thus, the Atg7 shoulder groove is built to recruit distinct distal structures from the two E2s in such a way as to allow each of their catalytic centers to approach the Atg7 active site.
E2 positioning through backside and edge binding to Atg7
Although prior qualitative studies suggested that Atg3's flexible region is essential for binding to Atg7 (ref. 27 ), additional contacts were implicated from the findings that Atg7 binds weakly to Atg3 lacking the flexible region, that Atg7's NTD binds with higher affinity to fulllength Atg3 than to a peptide corresponding to Atg3's flexible-region helix and that Atg3 binds with higher affinity to full-length Atg7 than to the isolated Atg7NTD 21 . Indeed, more than 30 Atg7 under-wing residues make more than 140 contacts to more than 25 residues from all four strands corresponding to the E2 core-domain backside of Atg3 as well as to several additional Atg3-specific loops (Fig. 4a and   Supplementary Fig. 5 ). Here, Atg7 and Atg3 interact through three regions that together comprise a roughly circular surface with an ~30-Å diameter. At the heart is a hydrophobic cluster involving Atg7's Phe16 and Phe61 and Atg3's Tyr168 and Phe189, buttressed by Atg7's Lys14 and Asp18, and backside surface side chains from Atg3, including Ser54, Arg72, Lys73, Asp170 and the backbone oxygen from Ser191.
We tested roles of this extensive secondary Atg7-Atg3 binding surface by using several assays. To probe interactions, we used our Atg7-Atg3 catalytic-cysteine cross-linking assay, and to probe enzymatic activity, we examined in vitro pulse-chase transfer of [ 32 P]Atg8 from Atg7 to Atg3. Consistent with key roles in stabilizing Atg7-Atg3 interactions and positioning their active sites, multiple alanine substitutions in place of Atg7 or Atg3 surface residues at the hydrophobic center of this interface resulted in severe defects in both in vitro assays (Fig. 4b-d) . For the highly deleterious K14A F16A D18A mutant, we confirmed proper folding with a crystal structure of this mutant version of Atg7NTD ( Supplementary Fig. 2b and Table 1 ). By contrast, mutations at the distal edge-Atg7 D47A N50A K53A or Atg3 K48A E51A Q302A D304A-had little effect on Atg7-Atg3 interactions in vitro.
To extend our analysis and study the effects of these Atg7 and Atg3 mutants in vivo, we examined their autophagy activity by four established methods: GFP-Atg8 localization, Pho8∆60 and GFP-Atg8 processing assays and an Atg8 lipidation assay (Fig. 4e,f and  Supplementary Fig. 6 ). During autophagy, GFP-Atg8 becomes ligated to PE and becomes localized to punctate dots, whereas it remains diffusely localized in the cytoplasm in yeast strains deficient in Atg8 lipidation. The second assay relies on Pho8∆60, a mutant form of vacuolar alkaline phosphatase, with 60 N-terminal amino acid residues deleted, that normally remains in the cytosol and is transported into the vacuole only through autophagy 29 . Measuring the activity of alkaline phosphatase thus reflects the level of autophagy. 
a r t i c l e s
In the third assay, GFP-Atg8 is delivered into the vacuole when autophagy is induced. Although Atg8 is degraded, the GFP moiety is relatively stable. Therefore, autophagy progression can be determined by the accumulation of free GFP 30 . Finally, we monitored Atg8 lipidation as a mobility shift on SDS-PAGE gels. Wild-type but not atg7∆ or atg3∆ cells transformed with empty vector displayed autophagy, as monitored by all four assays. Autophagy was restored in atg7∆ cells with a plasmid expressing either wild-type Atg7 or Atg7 D47A N50A K53A and in atg3∆ cells expressing wild-type Atg3. In contrast, autophagy was abolished in atg7∆ cells expressing Atg7 K14A F16A D18A or Atg7 F16A F61A or in atg3∆ cells expressing Atg3 R72A K73A Y168A, all of which contain mutations that localize to the center of the hydrophobic interface.
We were surprised to find that although Atg3 K48A E51A Q302A D304A, with mutations at the distal edge, showed little defect in Atg8 transfer from Atg7 to Atg3 in our in vitro assays, these mutations severely disrupted autophagy (Fig. 4b,f and Supplementary Fig. 6 ). Thus, it seemed possible that Atg3 uses this surface for downstream interactions in the pathway. Accordingly, we examined Atg8 lipidation with an in vitro assay in which Atg12~Atg5 acts as an E3 and PEcontaining liposomes provide substrate (Fig. 4g,h) . Consistent with the in vivo data, this mutant version of Atg3 is defective for generating the Atg8~PE product in vitro, which suggests potential roles for this surface in binding to E3 or substrate.
The Atg7 NTD-CTD junction region is also functionally important, as deleting Atg7 residues 290-294 or inserting the flexible sequence GGSG after Atg7's Leu291 leads to decreased cross-linking with Atg3 (Fig. 4d,i) . The insertion mutation was shown previously to decrease Atg7-mediated [ 32 P]Atg8 transfer to Atg3 (ref. 21) , and here we also observed similar defects for the deletion (Fig. 4j) .
The Atg7 under-wing region also interacts with Atg10's backside and edge (Fig. 5a) . However, unlike interactions with Atg3, Atg7's under-wing contacts to Atg10 are dispersed and lack a distinct center and thus may arise from crystallization or conformations imposed by cross-linking. Accordingly, multiple alanine substitutions in the underwing region of Atg7 had only a minor effect on cross-linking to Atg10 (Fig. 5b) . Furthermore, aligning either the Atg7NTDs or the E2s from the Atg7-Atg3 and Atg7-Atg10 complexes reveals relative displacement of the structural elements mediating interactions and different relative Atg7NTD and CTD orientations for juxtaposition of Atg7's active site with those of the two E2s (Figs. 1a and 2a,b and 5c) .
At the near edge, Ser290 and Leu291 from Atg7's NTD-CTD junction interact with Atg10's Leu96 and Leu98, with continued interactions involving the N-terminal helix of Atg7's NTD. Here, Atg7's Gln300 and Lys307 contact the backbone oxygens of Leu98 and Pro99 as well as Glu103 from Atg10. Additional electron density connecting Atg10's Val108 and Gly124 that is too low quality for accurate modeling reflects further contact with Atg7's NTD-CTD junction. Indeed, either deleting or inserting residues at the Atg7 NTD-CTD junction resulted in decreased cross-linking to Atg10 (Fig. 5b) .
Atg7 binding unmasks conserved E2 active site architectures
For both Atg3 and Atg10, the E2 active site is on the opposite face from the noncovalent Atg7-binding regions. In complex with Atg7, Atg3's catalytic Cys234 is surface exposed and is connected to additional patchy electron density that presumably corresponds to the BMOE also linked to Atg7's catalytic Cys507 ~7 Å away. Here, Atg3's cysteine [21] [22] [23] of unbound Atg7 (PDB 3VH2) or Atg8-bound Atg7CTD (PDB 3RUI) and the cross-linked Atg7-Atg3 complex described here, with the two Atg7 protomers colored in light and dark gray, orange and brown, and pink and violet, respectively. Atg3 is shown in cyan. Catalytic-cysteine sulfur atoms (or an oxygen in PDB 3RUI, which contains a C507S mutation) are shown as spheres. npg a r t i c l e s loop is substantially rearranged from the conformation observed in free Atg3, in which Cys234 is buried 27 (Fig. 6a) . Atg10's catalytic Cys133 is not observed in either complex in the asymmetric unit, which suggests that Atg10's cysteine loop is also conformationally flexible. Nonetheless, the location of Atg10's Cys133 can be approximated on the basis of the positions of His131 visible in one Atg10 and of Pro132 in the other Atg10 in the asymmetric unit. These are consistent with the subsequent Cys133 residue approaching Atg7's Cys507. Despite Atg10's catalytic cysteine not being visible and the limited resolution of our data, comparison of the Atg3 and Atg10 structures suggests a common active site architecture: Atg3's catalytic cysteine is flanked by Tyr179 and His232, and Atg10's Tyr73 and His131 are in parallel locations (Fig. 6b) . Notably, these are among the few amino acids shared between the sequences of Atg3s and Atg10s, which suggests key functions (Supplementary Fig. 4) . Indeed, Atg3 Y179A decreases pulse-chase transfer of [ 32 P]Atg8 from Atg7 to Atg3, and both mutants are defective in Atg8 lipidation in vitro, with a more pronounced defect observed for H232A (Fig. 6c,d) . Notably, these catalytic residues are required for Atg3 and Atg10 function in vivo (Fig. 6e,f) .
The conformation of the Atg7 cysteine loop when cross-linked to the E2s also differs from that in previous structures [21] [22] [23] . Prior studies had revealed that in the absence of a UBL, the Atg7 cysteine loop packs closely against the UBL-binding surface, with Cys507 facing toward the E1. However, in complex with Atg8, Atg7's cysteine loop is separated from the CTD and crosses over Atg8's C terminus. Notably, in different crystals of Atg7CTD-Atg8 complexes, Atg7's residues 504-508 are observed in different conformations, with Cys507 facing either toward or away from Atg8's C-terminal glycine 22, 23 . When cross-linked to the E2s but in the absence of a UBL, Atg7's cysteine loop adopts a hybrid conformation, with residues 490-505 packing against Atg7's UBL binding site, as observed previously, and residues 506-508 more open to allow Cys507 to face an E2 active site (Fig. 6g) .
DISCUSSION
The Atg7-Atg3 and Atg7-Atg10 crystal structures have revealed how the noncanonical E1 Atg7 recognizes its two cognate but distinct E2s. Both Atg3 and Atg10 are recruited by their E2 core-domain backsides to a broad surface extending over much of the unique Atg7NTD and including the junction with the Atg7CTD. Notably, Atg3-and Atg10-specific insertions anchor the complexes through docking in a distal Atg7NTD groove. Atg7NTD-mediated E2 backside recruitment, coupled with conformational flexibility, allows presentation of the active sites on the frontsides of Atg3 and Atg10 to the remote catalytic cysteine in the UBL-binding CTD from the opposite Atg7 monomer in the homodimer.
In addition to functioning with these two divergent E2s, Atg7 is distinct among E1s in activating two divergent UBLs, Atg8 and Atg12. It is currently thought that Atg8 is strictly directed to Atg3 as its specific E2 for ligation to PE 31 , with Atg10 being the exclusive E2 for Atg12 ligation to Atg5 (ref. 32) . However, there is much crosstalk between the pathways. For example, the Atg12~Atg5 complex is an E3 that promotes Atg8 transfer from Atg3's active site to PE 6 . Conversely, in mammalian cells, Atg3 overexpression facilitates formation of the Atg12~Atg5 complex 33 , and during mitophagy Atg3 can also act as an Atg12 E2 mediating self-modification 34 . Irrespective of whether there are circumstances under which Atg8 and Atg12 could both function with Atg3 and/or Atg10, it is clear that, at least in vitro, Atg8 is preferentially transferred to Atg3.
Two speculative models emerge for how Atg7 UBL and E2 specificity could be established. Briefly, we made a model of Atg3-Atg7~Atg8 by superimposing the Atg7-Atg3 structure with a prior Atg7CTD-Atg8 structure 23 and (i) docked the Atg8 globular domain, (ii) transplanted residues 490-506 from the Atg7 cysteine loop in the Atg8-bound complex and (iii) positioned Atg8's C-terminal tail as in a thioester complex by superimposing it on Atg7's cysteine loop, residues 504-506, from the structures lacking Atg8 (Fig. 7a) . The structural model reveals the Atg7 cysteine loop contacting both Atg8 and Atg3. Thus, the Atg7 cysteine loop may be the sensor that transmits signals between the UBL and the E2 for optimal interaction and/or catalysis of UBL transfer. The second mechanism is suggested by a parallel model of Atg10-Atg7~Atg12 (Fig. 7b) . Here, Atg10's residues 133-145, including Cys133, are not modeled because they were not visible in the electron density. However, the locations of the adjoining Atg10 residues Pro132 and Met146 suggest that the E2 cysteine loop may also directly recognize its cognate UBL during the transthiolation reaction. Future structural studies of Atg3-Atg7~Atg8 and Atg10-Atg7~Atg12 complexes will be required to understand the extent to which the E1 and E2 cysteine loops or other features dictate UBL specificity of E1-to-E2 transfer in autophagy.
In addition to having implications for autophagy, our data also broadly show how one E1 uses the same surfaces to bind distinctive elements from two different E2s. Although the mechanisms by which Atg7 recruits Atg3 and Atg10 differ from those by which canonical E1 UFDs recruit E2s (Supplementary Fig. 7) , some common principles emerge: In all cases, E2s are anchored to E1 domains through surfaces remote from the active sites, with the E1 domains probably rotating to bring the E1 and E2 catalytic cysteines into proximity for catalysis 16, 25 . 
npg a r t i c l e s
Furthermore, Atg3 and Atg10 now join a long list of E2s for which key interactions involve the backside β-sheet 35 (Supplementary Fig. 7 ). Many E2s for ubiquitin, and also the SUMO E2 Ubc9 (refs. 36-38) , backside bind noncovalently to their cognate UBL. This can promote polyUBL chain synthesis through unknown mechanisms 35, 38 . For the ubiquitin E2 Ube2g2, backside binding to a helix from the E3 gp78 allosterically promotes polyubiquitin chain synthesis 39, 40 . Notably, the E2 Rad6 can backside bind in a mutually exclusive manner to ubiquitin or to a helix from the E3 Rad18, the latter restraining activity to monoubiquitination 41 . As with ubiquitin and SUMO E2s, Atg3 and Atg10 make numerous protein-protein interactions in addition to those with Atg7. It will be interesting in the future to learn whether other E2-mediated steps in autophagy, such as during Atg12~Atg5 enhancement of Atg8 transfer from Atg3 to PE, also involve interactions near or at autophagy E2 backsides.
